PHARMACIE SQUELARD
De berekende faillissementskans van PHARMACIE SQUELARD over 12 maanden bedraagt 0,7% (laag). Het bedrijf is actief sinds 2000 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 25 jaar |
| Vestigingen | 1 |
| Publicaties | 1 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | volledig | 26-05-2026 | 2026-00128200 |
| 31-12-2024 | volledig | 29-06-2025 | 2025-00209961 |
| 31-12-2023 | volledig | 24-07-2024 | 2024-00279379 |
| 31-12-2022 | volledig | 12-07-2023 | 2023-00234468 |
| 31-12-2021 | volledig | 05-07-2022 | 2022-20167426 |
| 31-12-2020 | volledig | 26-08-2021 | 2021-54000084 |
| 31-12-2019 | volledig | 20-07-2020 | 2020-32200180 |
| 31-12-2018 | volledig | 28-06-2019 | 2019-25700471 |
| 31-12-2017 | volledig | 22-06-2018 | 2018-21500101 |
| 31-12-2016 | volledig | 20-07-2017 | 2017-34200320 |
| NACE primair | Detailhandel in farmaceutische producten(47730) |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 26-10-2000 |
| Status | Actief |
| Postcode | 5651 |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
Wij kennen 2 Staatsblad-aktes van dit bedrijf. Daarvan is er nog geen enkele gelezen: wat erin staat, is hier niet vastgesteld en ook niet weerlegd.
23-12-2021 Kapitaalvermindering van €399.520 tot €0
- €399.520 → €0
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": 0.0,
"delta_eur": -399520.0,
"before_eur": 399520.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "distribution_to_shareholders",
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": 399520.0,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": null,
"n_new_shares": 200,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Ang\u00E9lique SQUELARD",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 1716,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Aurore SQUELARD",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 1716,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": 36320.0,
"delta_eur": -36320.0,
"before_eur": 399520.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "distribution_to_shareholders",
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": 36320.0,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Val\u00E9rie Depouhon",
"firm_city": null,
"firm_name": null,
"office_city": "Courcelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2021-12-23",
"filing_date": "2021-12-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2021-12-16",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0473.132.643",
"name_full": "PHARMACIE SQUELARD",
"legal_form": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Val\u00E9rie Depouhon",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire"
},
"co_filed_documents": [
"Exp\u00E9dition de l\u2019acte",
"Statuts coordonn\u00E9s"
],
"shareholders_after": [],
"share_classes_after": []
}| Officiële naamFR | PHARMACIE SQUELARD |